These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 745697)

  • 1. The accumulation of (3H) enkephalinamide (2-D-alanine-5-methioninamide) in rat brain tissues.
    Huang JT; Lajtha A
    Neuropharmacology; 1978 Dec; 17(12):1075-9. PubMed ID: 745697
    [No Abstract]   [Full Text] [Related]  

  • 2. Accumulation of amino acids, met-enkephalinamide and morphine in choroid plexus: effect of pretreatment with phosphatidylcholine vesicles.
    Huang JT
    Res Commun Chem Pathol Pharmacol; 1980 Jun; 28(3):567-70. PubMed ID: 7403669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [D-Alanine2]-methionine enkephalinamide binding to rat brain slices: differences from opiate alkaloid binding and reduction by chronic morphine treatment.
    Davis ME; Akera T; Brody TM
    Life Sci; 1978 Dec; 23(27-28):2675-80. PubMed ID: 739845
    [No Abstract]   [Full Text] [Related]  

  • 4. Binding and metabolism studies with [3H](D-Ala2,Leu5)enkephalinamide and [3H](D-Ala2,Pro5)enkephalinamide: evidence for a selective interaction of (D-Ala2,Pro5)enkephalinamide with mu-receptors.
    Audigier Y; Mazarguil H; Roy J; Morgat JL; Cros J
    Eur J Pharmacol; 1981 Sep; 74(4):273-8. PubMed ID: 6271558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxazone irreversibly inhibits the high affinity binding of [125I]D-ala2-D-leu5-enkephalin.
    Hazum E; Chang KJ; Cuatrecasas P; Pasternak GW
    Life Sci; 1981 Jun; 28(26):2973-9. PubMed ID: 6267402
    [No Abstract]   [Full Text] [Related]  

  • 6. Allosteric modulation by leucine-enkephalin of [3H]naloxone binding in rat brain.
    Rothman RB; Westfall TC
    Eur J Pharmacol; 1981 Jul; 72(4):365-8. PubMed ID: 6268425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extremely rapid degradation of [3H] methionine-enkephalin by various rat tissues in vivo and in vitro.
    Dupont A; Cusan L; Garon M; Alvarado-Urbina G; Labrie F
    Life Sci; 1977 Oct; 21(7):907-14. PubMed ID: 927020
    [No Abstract]   [Full Text] [Related]  

  • 8. Methionine-enkephalin transport by choroid plexus.
    Brand N; Firemark H
    Trans Am Neurol Assoc; 1978; 103():242-4. PubMed ID: 757067
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of binding of [3H]-methionine-enkephalin, [3H]-naltrexone and [3H]-dihydromorphine in the mouse vas deferens and the myenteric plexus and brain of the ginea pig.
    Leslie FM; Kosterlitz HW
    Eur J Pharmacol; 1979 Jul; 56(4):379-83. PubMed ID: 477732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective protection of stereospecific enkephalin and opiate binding against inactivation by N-ethylmaleimide: evidence for two classes of opiate receptors.
    Smith JR; Simon EJ
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):281-4. PubMed ID: 6244551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics as inhibitors of enkephalin degradation by human brain.
    Traficante LJ; Siekierski J; Rotrosen J; Gershon S
    Pharmacol Res Commun; 1980 Jun; 12(6):575-80. PubMed ID: 7403230
    [No Abstract]   [Full Text] [Related]  

  • 12. Classification of multiple morphine and enkephalin binding sites in the central nervous system.
    Wolozin BL; Pasternak GW
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6181-5. PubMed ID: 6273857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential postnatal development of mu and delta opiate receptors.
    Wohltmann M; Roth BL; Coscia CJ
    Brain Res; 1982 Apr; 255(4):679-84. PubMed ID: 6280810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of methionine-enkephalin and naloxone binding sites in regions of rat brain.
    Tsang D; Ng SC; Ho KP
    Brain Res; 1982 Apr; 255(4):637-44. PubMed ID: 6280806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The actions of naloxazone on the binding and analgesic properties of morphiceptin (NH2Tyr-Pro-Phe-Pro-CONH2), a selective mu-receptor ligand.
    Zhang AZ; Chang JK; Pasternak GW
    Life Sci; 1981 Jun; 28(25):2829-36. PubMed ID: 6267398
    [No Abstract]   [Full Text] [Related]  

  • 17. Regional release of [3H]dopamine from rat brain in vitro: effects of opioids on release induced by potassium, nicotine, and L-glutamic acid.
    Marien M; Brien J; Jhamandas K
    Can J Physiol Pharmacol; 1983 Jan; 61(1):43-60. PubMed ID: 6132674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the pituitary in the diurnal variation in tolerance to painful stimuli and brain enkephalin levels.
    Wesche DL; Frederickson RC
    Life Sci; 1981 Nov; 29(21):2199-205. PubMed ID: 7198705
    [No Abstract]   [Full Text] [Related]  

  • 19. Differentiation of agonist conformation and antagonist conformation in multiple opioid receptors.
    Ogawa N; Yamawaki Y; Kuroda H; Nukina I; Ofuji T
    Neurosci Lett; 1981 Dec; 27(2):205-9. PubMed ID: 6275320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate receptor heterogeneity in human brain regions.
    Bonnet KA; Groth J; Gioannini T; Cortes M; Simon EJ
    Brain Res; 1981 Sep; 221(2):437-40. PubMed ID: 6269694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.